Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
GENFIT S.A.
GENFIT: June 15, 2026 Combined Shareholders Meeting Results
June 15, 2026
GENFIT: NASHnext®, Powered by GENFIT’s Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASH
June 8, 2026
GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026
May 27, 2026
GENFIT Reports First Quarter 2026 Financial Information and Provides a Corporate Update
May 27, 2026
GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents
May 25, 2026
GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025)
May 22, 2026
GENFIT Announces Publication of the 2025 Universal Registration Document
May 20, 2026
GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update
May 20, 2026
GENFIT Receives FDA Orphan Drug Designation for NTZ for the treatment of ACLF
May 19, 2026